News

Sarepta shares hit as Mizuho, Leerink warn on FDA rift, credibility risk
Investing.com -- Sarepta Therapeutics came under pressure after two brokerages slashed their price targets and downgraded the stock, flagging mounting safety, regulatory, and credibility concerns ...
Managed care needs to improve to improve health care sector, says Mizuho's Jared Holz
Jared Holz, Mizuho health care sector strategist, joins 'The Exchange' to discuss the pain in the health care sector and if ...
Health Care Roundup: Market Talk
The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...
Northern Oil and Gas (NOG) Fell This Week. Here is Why.
"attachment_1205747" align="aligncenter" width="1456"] An aerial view of an oil and gas platform in the middle of the ocean, ...
Jefferies, Mizuho, and Morgan Stanley top M&A value in South & Central America in H1 2025
Jefferies, Mizuho Financial Group, and Morgan Stanley have emerged as the leading mergers and acquisitions (M&A) financial ...
The Manila Times13h
Transaction in Own Shares
In accordance with Article 5 (1) (b) of Regulation (EU) No 596/2014 (the Market Abuse Regulation), (as in force in the UK and as amended by the Market Abuse (Amendment) (EU Exit) Regulations 2019), ...
Japan ruling party's election loss is in the price, investors say
Japan's upper house election on Sunday dealt a big blow to the ruling coalition and sets markets up for possible policy ...